United States · Resolution · HRES
H.Res. 484 (117th)
Expressing the sense of the House of Representatives that the United States should not waive intellectual property rights relating to COVID-19 vaccines or treatments.
Introduced
17 June 2021
Last action
—
Status
Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.
Sponsors
—
Subjects
Discovery layer
Source updated
16 January 2025
Summary
This resolution expresses the sense of the House of Representatives that the United States should not waive intellectual property protections for COVID-19 vaccines, treatments, or other related innovations.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN · 17 June 2021
Introduced in House (PDF)
Introduced in House · EN · 17 June 2021
Introduced in House
summary · EN · 17 June 2021
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/117th-congress/house-resolution/484
- Open data entity: https://api.congress.gov/v3/bill/117/hres/484